AGM results statement June 2018 Paris, France and Cambridge, UK – 12 June 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, yesterday held its Annual General Meeting (AGM). The results of the AGM are set out in the table below, with the Company pleased to announce that all resolutions
Visit PageCategory: Uncategorized
NOVACYT LAUNCHES NEW PRODUCT IN INFECTIOUS MONONUCLEOSIS
New product launch under PathFlow brand First in a series of new product launches in infectious diseases
Visit PageNovacyt expands distribution presence in Asia Pacific
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces that it has appointed MDL Asia Pty Ltd (“MDL” or “MDL Asia”) as its marketing and distribution partner in the Asia Pacific region, excluding Greater China. Download press release
Visit Page